Product Carbon Footprints: The Next Frontier In Sustainable Innovation

Reducing carbon emissions starts with understanding them, and for biopharma, that means looking beyond operations to the full product lifecycle. Product Carbon Footprints (PCFs) provide a 360-degree view of emissions from raw materials to disposal, offering the precision needed to tackle Scope 3 emissions, which account for the majority of industry impact. Moving from spend-based estimates to primary, product-specific data transforms sustainability from compliance to innovation, enabling collaboration across the value chain. Standardized PCF methodologies are critical for transparency and scalability, paving the way for shared data and actionable insights. As expectations rise, PCF data is set to influence procurement, regulatory reporting, and even drug labeling, empowering informed choices.
The future belongs to those who measure and act. Access the full article to learn why PCFs are the key to unlocking that future.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.